This study identifies variation in open Roux-en-Y gastric bypass surgeries by health insurance status.
This population-based study uses data from a large health claims database to evaluate the incidence of bone fracture and characteristics that may be associated with nonunion of the fractures.
This study examines 10-year weight change in veterans who underwent Roux-en-Y gastric bypass compared with nonsurgical matches and the 4-year weight change in veterans who underwent Roux-en-Y gastric bypass, adjustable gastric banding, or sleeve gastrectomy.
This study examines whether gastric bypass surgery is equally effective in reducing mortality in groups undergoing surgery at different ages.
This survey study examines patients’ self-reported presence and severity of symptoms and quality of life after Roux-en-Y gastric bypass surgery.
This study evaluated improvement in obesity-related comorbidities after bariatric surgery and identified clinical factors associated with these responses.
This article reviews the pathophysiology, clinical presentation, diagnostic evaluation, and treatment of gastroesophageal reflux disease.
This cohort study compares the 5-year efficacy of gastrointestinal metabolic surgery vs medical treatment for type 2 diabetes mellitus in mildly obese patients.
This study hypothesizes that safe and reasonable outcomes can be achieved when single-port laparoscopy is used before a right hemicolectomy for obese patients.
This cohort study evaluates the long-term effects of laparoscopic sleeve gastrectomy on obesity-related comorbidities.
This randomized clinical trial reports that bariatric surgery with 2 years of an adjunctive low-level lifestyle intervention resulted in more disease remission than did lifestyle intervention alone for obese participants with type 2 diabetes mellitus.
This retrospective review identifies a progressive increase over time in the prevalence of obesity, diabetes, left main coronary artery disease, and advanced New York Heart Association heart failure class among patients undergoing CABG.
This randomized clinical trial reports that in patients with a body mass index of 50 to 60 kg/m2, duodenal switch resulted in greater weight loss and greater improvements in low-density lipoprotein cholesterol, triglycerides, and glucose 5 years after surgery compared with gastric bypass while improvements in health-related quality of life were similar.